Literature DB >> 19880176

The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses.

Qianjun He1, Jiamin Zhang, Jianlin Shi, Ziyan Zhu, Linxia Zhang, Wenbo Bu, Limin Guo, Yu Chen.   

Abstract

Highly ordered MCM-41-type mesoporous silica nanoparticles (MSNs) with particle sizes of 150 +/- 20 nm were prepared and PEGylated by covalently grafting PEGxk chains of different molecular weights (x = 4, 6, 10, 20) and chain densities (0.05 wt%-3.75 wt%) on the outer surface. The influence of molecular weights and chain densities of PEGxk on the nonspecific binding of PEGylated MSNs to human serum protein (HSA) was investigated. The results revealed that the optimal molecular weights should be not less than 10k, and the corresponding optimal chain densities for PEG10k-MSNs and PEG20k-MSNs were 0.75 wt% and 0.075 wt%, respectively, and the resultant minimum HSA adsorbance (2.5%) on PEGxk-MSNs was far less than that on MSNs (18.7%) without PEGylation. Under the optimal conditions for the minimum HSA adsorbance, the phagocytosis of human THP-1 monocytic leukemia cell line-derived macrophages (THP-1 macrophages) and the hemolysis of human red blood cells (HRBCs) were investigated with MSNs and PEGylated MSNs. A minimum THP-1 phagocytosis percentage (0.1%) and a very low HRBCs hemolysis percentage (0.9%) of PEG10k-MSNs were obtained, which were much lower than those (8.6% and 14.2%, respectively) of MSNs. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880176     DOI: 10.1016/j.biomaterials.2009.10.046

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  55 in total

Review 1.  Nanoparticle systems for cancer vaccine.

Authors:  Ru Wen; Afoma C Umeano; Yi Kou; Jian Xu; Ammad Ahmad Farooqi
Journal:  Nanomedicine (Lond)       Date:  2019-02-26       Impact factor: 5.307

2.  Nonporous Silica Nanoparticles for Nanomedicine Application.

Authors:  Li Tang; Jianjun Cheng
Journal:  Nano Today       Date:  2013-06       Impact factor: 20.722

3.  Monocyte-targeting supramolecular micellar assemblies: a molecular diagnostic tool for atherosclerosis.

Authors:  Eun Ji Chung; Laurie B Mlinar; Kathryn Nord; Matthew J Sugimoto; Emily Wonder; Francis J Alenghat; Yun Fang; Matthew Tirrell
Journal:  Adv Healthc Mater       Date:  2014-08-22       Impact factor: 9.933

4.  Interaction of colloidal nanoparticles with their local environment: the (ionic) nanoenvironment around nanoparticles is different from bulk and determines the physico-chemical properties of the nanoparticles.

Authors:  Christian Pfeiffer; Christoph Rehbock; Dominik Hühn; Carolina Carrillo-Carrion; Dorleta Jimenez de Aberasturi; Vivian Merk; Stephan Barcikowski; Wolfgang J Parak
Journal:  J R Soc Interface       Date:  2014-04-23       Impact factor: 4.118

5.  DNA-Assembled Core-Satellite Upconverting-Metal-Organic Framework Nanoparticle Superstructures for Efficient Photodynamic Therapy.

Authors:  Liangcan He; Michael Brasino; Chenchen Mao; Suehyun Cho; Wounjhang Park; Andrew P Goodwin; Jennifer N Cha
Journal:  Small       Date:  2017-05-08       Impact factor: 13.281

6.  Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles.

Authors:  Saijie Zhu; Mengmeng Niu; Hannah O'Mary; Zhengrong Cui
Journal:  Mol Pharm       Date:  2013-08-06       Impact factor: 4.939

7.  Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release.

Authors:  Jinping Lai; Birju P Shah; Eric Garfunkel; Ki-Bum Lee
Journal:  ACS Nano       Date:  2013-03-11       Impact factor: 15.881

8.  Cellular Endocytosis and Trafficking of Cholera Toxin B-Modified Mesoporous Silica Nanoparticles.

Authors:  William A Walker; Mubin Tarannum; Juan L Vivero-Escoto
Journal:  J Mater Chem B       Date:  2016-01-07       Impact factor: 6.331

Review 9.  Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.

Authors:  Worapol Ngamcherdtrakul; David J Castro; Shenda Gu; Jingga Morry; Moataz Reda; Joe W Gray; Wassana Yantasee
Journal:  Cancer Treat Rev       Date:  2016-02-22       Impact factor: 12.111

Review 10.  PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

Authors:  Jung Soo Suk; Qingguo Xu; Namho Kim; Justin Hanes; Laura M Ensign
Journal:  Adv Drug Deliv Rev       Date:  2015-10-09       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.